Complications of portal hypertension, including ascites, gastrointestinal bleeding, hepatic
hydrothorax, and hepatic encephalopathy, are associated with significant morbidity and …

The clinical course of cirrhosis is mostly determined by the progressive increase of portal
hypertension, hyperdynamic circulation, bacterial translocation and activation of systemic …

1 ESGE recommends that patients with compensated advanced chronic liver disease
(ACLD; due to viruses, alcohol, and/or nonobese [BMI< 30 kg/m 2] nonalcoholic …

The prevention and management of bleeding and thrombosis in patients with cirrhosis
poses several difficult clinical questions. These Clinical Practice Guidelines have been …

This guidance provides a data-supported approach to risk stratification, diagnosis, and
management of patients with cirrhosis and portal hypertension (PH). A guidance document …

Abstract Background and Aims Alcohol-related liver disease is a leading cause of liver-
related mortality. The effect of alcohol abstinence on the natural history of alcohol-related …

Background The survival benefit of early placement of transjugular intrahepatic
portosystemic shunts (TIPS) in patients with cirrhosis and acute variceal bleeding is …

Background & Aims Distinct prognostic stages of advanced chronic liver disease (ACLD) are
defined by severity of portal hypertension (PH) and the presence/absence of clinical …

These updated guidelines on the management of variceal haemorrhage have been
commissioned by the Clinical Services and Standards Committee (CSSC) of the British …

Background & Aims Patients with cirrhosis with acute variceal bleeding (AVB) have high
mortality rates (15%–20%). Previously described models are seldom used to determine …